טוען...
Higher Medical Care Costs Accompany Impaired Fasting Glucose: “Costs of IFG”
OBJECTIVE: To estimate medical costs associated with elevated fasting plasma glucose (FPG), and to determine whether costs differed for patients who met the 2003 (≥ 100 mg/dl) versus the 1997 (≥ 110mg/dl) ADA cut-point for impaired fasting glucose. RESEARCH DESIGN AND METHODS: We identified 28,335 p...
שמור ב:
| Main Authors: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2005
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1383774/ https://ncbi.nlm.nih.gov/pubmed/16123494 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|